JN
Jack Nielsen
Managing Partner at Vivo Capital
JN
Jack Nielsen
Managing Partner at Vivo Capital
Palo Alto, California
Overview
Work Experience
Managing Partner
2017 - Current
Consultant
2017 - 2017
Board Member
2021
Board Member
2021
IO Biotech went public on Nasdaq in November 2021 under Ticker IOBT
Board Member
2020
Instil Bio went public on Nasdaq in March 2021 under Ticker TIL
Board Member
2020
ALX Oncology went public on Nasdaq in July 2020 under Ticker ALXO
Chairman / Lead Director
2018
Aligos went public on Nasdaq in October 2020 under Ticker ALGS
Board Member
2017
Harmony Biosciences went public on NASDAQ August 2020 under ticker HRMY
Lead Director - Board Member
2006 - 2022
Reata went public on Nasdaq in May 2016 under Ticker RETA. Acquired by Biogen in 2023 for $7.3 BUSD
Board Member
2019 - 2022
LumiThera acquired the Maculogix in 2022
Board Observer
2018 - 2020
Passage Bio raised 216 MUSD in an IPO on NASDAQ under ticker PASG